Wednesday, September 8th, 2010


Volume 45
Number 8
   
609
Allan B. MacLean, M.D., FRCOG, Wendy M. N. Reid, M.B.B.S., MRCOG, Kerstin J. Rolfe, B.Sc., Samantha J. Gammell, B.Sc., M.B.B.S., Harry E. J. Pugh, M.B.B.S., Kevin C. Gatter, D.Phil., M.R.C.Path., Ann-Christine Wong Te Fong, Dip. Histotech, Microscop. Electron., Julie C. Crow, M.D., F.R.C.Path., and Christopher W. Perrett, Ph.D., M.R.S.C.
Demonstration of angiogenesis may suggest which preinvasive lesions will progress to invasive cancer.


613
Elmar A. Joura, M.D., Alexander Lˆsch, M.D., Maria-Gabriela Haider-Angeler, M.D., Gerhard Breitenecker, M.D., and Sepp Leodolter, M.D.
Over the past decade a striking increase occurred in the incidence of vulvar intraepithelial neoplasia and invasive vulvar squamous cell carcinoma in young women.


616
Annarosa Virgili, M.D., Andrea Marzola, M.D., and Monica Corazza, M.D.
Because of the rarity of hidradenoma papilliferum, physicians do not gain enough experience with the tumor to recognize it.


619
Gordon Davis, M.D., Jeffrey Wentworth, M.D., and Janet Richard, R.N.C., N.P.
Imiquimod may be an effective treatment modality for viral vulvar intraepithelial neoplasia 3 in the future.


624
Barbara D. Reed, M.D., M.S.P.H., Hope K. Haefner, M.D., Margaret R. Punch, M.D., Randy S. Roth, Ph.D., Daniel W. Gorenflo, Ph.D., and Brenda W. Gillespie, Ph.D.
Women with vulvodynia are psychologically similar to control women but differ significantly from women with chronic pelvic pain.


633
Peer Hantschmann, M.D., and Rainer K¸rzl, M.D.
In squamous cell carcinoma of the vulva, inhibition of apoptosis is associated with a more-aggressive phenotype, and a Bcl-2-positive inflammatory infiltrate is predictive of prognosis.


643
Jacob Bornstein, M.D., M.P.A., Nitza Lahat, Ph.D., Avishalom Sharon, M.D., Haifa Gazawi, B.Sc., Haim Abramovici, M.D., and Michal A. Rahat, D.Sc.
In vulvar vestibulitis, telomerase activity may be increased as a result of infection with HPV type 16/18.


649
Andrea Bauer, M.D., Johannes Geier, M.D., and Peter Elsner, M.D.
For patch testing in patients with anogenital eczema, we recommend using the standard series, dibucaine HCl, propolis, bufexamac and other ingredients in topical preparations.


655
Ai Ling Tan, FRANZCOG, Ronald Jones, FRCOG, Georgina Mcpherson, SRN, and Darion Rowan, FRACD
Provision of a multidisciplinary vulvar clinic in a tertiary care setting provides an invaluable service for both primary and secondary clinical practitioners.


659
Debra S. Heller, M.D., Bernadette Cracchiolo, M.D., M.P.H., Meera Hameed, M.D., and Tanya May, M.D.
This case demonstrates the need to biopsy all suspicious vulvar lesions, even in young and pregnant women.


662
Annarosa Virgili, M.D., Albino Bianchi, M.D., Gioacchino Mollica, M.D., and Monica Corazza, M.D.
Management of vulvar hematomas may range from conservative to surgical, with drainage and incision advised for more severe cases to reduce infective complications and hospitalization.


665
Hope K. Haefner, M.D., Mohammad H. Khoshnevisan, D.M.D., D.P.H.Dent., Jan E. Bachman, Ph.D., Heather D. Flowe-Valencia, M.A., Carmen R. Green, M.D., and Barbara D. Reed, M.D., M.S.P.H.
Patients with vulvar pain are a unique group when compared to other chronic pain populations.


672
JosÈ A. Fonseca-Moutinho, M.D., Maria C. Coelho, M.D., and Daniel P. Silva, M.D.
Metastases in two or more groin nodes had a strong relation to local recurrence, and postoperative radiotherapy is advisable.


679


685
Igal Wolman, M.D., Asnat Groutz, M.D., Ilan Gull, M.D., David Gordon, M.D., Eli Geva, M.D., Joseph B. Lessing, M.D., and Ariel J. Jaffa, M.D.
Fasting may reduce the amniotic fluid volume, as shown by the AFI, and fluid intake may restore the normal amount of amniotic fluid volume.


688
Cleusa C. Dias, M.D., Jurandyr M. Andrade, M.D., Rui A. Ferriani, M.D., Marcia G. Villanova, M.D., and Roberto S. Meirelles, M.D.
Bloody ascites should be considered a complication of endometriosis, especially in nulliparous women of childbearing age.


 

The opinions and statements in this journal are those of the authors and are not attributable to the sponsor, publisher, editors or editorial board of JRM. Product dosages, indications and methods of use referred to in the papers and discussions reflect the authors' clinical experience or are derived from other professional sources.